Evidence map›Paper›PMID 24466434›Full record

ReviewEuropean journal of microbiology & immunology2011

C-type lectins with a sweet spot for Mycobacterium tuberculosis.

G Lugo-Villarino, D Hudrisier, A Tanne, O Neyrolles

Open access · hybridAbstract readReview
In one paragraph

Review in European journal of microbiology & immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Innate immune recognition ofCell surface (Amsterdam, Netherlands) · 2025
    Review
  2. Review
  3. The mannose receptor ligands and the macrophage glycome.Current opinion in structural biology · 2022
    Review
  4. Article
  5. Review
  6. Collectins: Innate Immune Pattern Recognition Molecules.Advances in experimental medicine and biology · 2020
    Review
  7. Lectins ofBeilstein journal of organic chemistry · 2019
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. C-type lectin receptors in tuberculosis: what we know.Medical microbiology and immunology · 2016
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

G Lugo-Villarino
D Hudrisier
A Tanne
O Neyrolles
Université Fédérale de Toulouse Midi-Pyrénées · FRHarvard University · USInstitut de Pharmacologie et de Biologie Structurale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pattern of receptors sensing pathogens onto host cells is a key factor that can determine the outcome of the infection. This is particularly true when such receptors belong to the family of pattern recognition receptors involved in immunity. Mycobacterium tuberculosis, the etiologic agent of tuberculosis interacts with a wide range of pattern-recognition receptors present on phagocytes and belonging to the Toll-like, Nod-like, scavenger and C-type lectin receptor families. A complex scenario where those receptors can establish cross-talks in recognizing pathogens or microbial determinants including mycobacterial components in different spatial and temporal context starts to emerge as a key event in the outcome of the immune response, and thus, the control of the infection. In this review, we will focus our attention on the family of calcium-dependent carbohydrate receptors, the C-type lectin receptors, that is of growing importance in the context of microbial infections. Members of this family appear to be key innate immune receptors of mycobacteria, capable of cross-talk with other pattern recognition receptors to induce or modulate the inflammatory context upon mycobacterial infection.

Indexed as

C-type lectindendritic cellmacrophagemycobacteriapattern recognition receptortuberculosis

Identifiers

PMID24466434
PMCPMC3894812
OpenAlexW2145664563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.